At the critical moment of the fight against the new coronavirus epidemic, the new coronavirus (2019-nCoV) lgM/lgG antibody detection kit jointly developed by Shenzhen Wuweihuasi Biotechnology Co., Ltd. and Shenzhen Third People’s Hospital has been developed and passed The preliminary clinical verification requires only a drop of blood to complete the test within ten minutes.

outine nucleic acid testing plays an irreplaceable role in diagnosing new coronavirus infection, but due to its cumbersome operation, time-consuming, and high requirements for laboratories and technicians, it is not suitable for rapid screening of suspected patients and close contacts. At the same time, considering that the main infection sites of the new coronavirus are in the lower respiratory tract and lungs, taking a throat swab to take a sample of the upper respiratory tract may lead to false negative results. In contrast, the detection of specific antibodies produced by the human body has the characteristics of convenient sampling and high detection efficiency. It can be used as an effective supplement to nucleic acid detection and cross-validation. It is helpful for early screening of new coronavirus infections and rapid completion of confirmed patients and The screening of suspected patients enables the early isolation of confirmed patients and reduces the manpower and material resources consumed by patient isolation in the later stage, which is helpful for epidemic control. The new coronavirus lgM/lgG antibody combined detection kit developed by Wuweihuasi significantly improves the sensitivity of detection by jointly detecting lgM and lgG antibodies in the blood. The diagnostic reagent is currently undergoing clinical verification work for suspected infected persons, close contacts, and confirmed cases in Shenzhen Third People's Hospital.

Shenzhen Wuweihuasi Biotechnology Co., Ltd. is a national high-tech enterprise incubated by the Shenzhen Peacock Technology Innovation Team. It has gathered a group of experts and scholars from internationally renowned universities. The antibody detection kit developed by it just makes up for the defects of nucleic acid detection. , Can realize fast, large-scale batch production.

In addition, in order to cope with the prevention and control of the epidemic after the company resumes work, the park will recently cooperate with Shenzhen Wuweihuasi Biotechnology Co., Ltd. to provide employees of the park with new coronavirus infection testing services for non-clinical diagnostic purposes on a voluntary basis.